Probi, part of Symrise group, joins new Care & Wellness Division. Read more here.
We will be at Infarma, one of the largest pharmacy events within the region, in Madrid on March 24. Hope to be able to connect with you there!
On 20 November 2024, Probi AB’s (“Probi”) principal shareholder and parent company Symrise AG (“Symrise”) announced that Symrise is making a public takeover offer to the shareholders of Probi for SEK 350 per Probi share (the “Offer”). The acceptance period for the Offer is expected to commence on 18 December 2024 and end on or about 15 January 2025.
Read more on Symrise’s website, www.symrise.com/de/probi.
Probi’s Board comments on Symrise’s public takeover offer
Probi applies for delisting and convenes an Extraordinary General Meeting
